Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 37.80
-0.25 (-0.66%)
Sep 8, 2026, 1:30 PM CST
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.41 billion as of September 8, 2026. Its market cap has decreased by -11.92% in one year.
Market Cap
3.41B
Enterprise Value
2.52B
Revenue
837.44M
Ranking
n/a
PE Ratio
11.83
Stock Price
37.80
ChartMarket Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has decreased from 3.53B to 3.41B, a decrease of -3.20%. That is a compound annual growth rate of -0.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.41B | -11.10% |
| Dec 31, 2025 | 3.84B | -12.06% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 7.10B |
| Pacific Hospital Supply | 5.66B |
| Formosa Optical Technology | 5.50B |
| St.Shine Optical | 4.97B |
| Bionime | 4.53B |
| ICARES Medicus | 3.67B |
| SciVision Biotech | 3.52B |
| Nang Kuang Pharmaceutical | 3.22B |